BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caldera F, Ley D, Hayney MS, Farraye FA. Optimizing Immunization Strategies in Patients with IBD.Inflamm Bowel Dis. 2021;27:123-133. [PMID: 32232388 DOI: 10.1093/ibd/izaa055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Rong JM, Luo J, Huang Q, Miao YL. Individualized selection of biological agents in treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 893-900 [DOI: 10.11569/wcjd.v29.i15.893] [Reference Citation Analysis]
2 Gong W, Yu J, Zheng T, Liu P, Zhao F, Liu J, Hong Z, Ren H, Gu G, Wang G, Wu X, Zhao Y, Ren J. CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease. Clin Transl Med 2021;11:e339. [PMID: 33634985 DOI: 10.1002/ctm2.339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Desalermos A, Pimienta M, Kalligeros M, Shehadeh F, Diamantopoulos L, Karamanolis G, Caldera F, Farraye FA. Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2021:izab266. [PMID: 34849941 DOI: 10.1093/ibd/izab266] [Reference Citation Analysis]
4 Wu X, Lin J, Buch H, Ding Q, Zhang F, Cui B, Ji G. The COVID-19 Vaccination Hesitancy Among the People With Inflammatory Bowel Disease in China: A Questionnaire Study. Front Public Health 2021;9:731578. [PMID: 34708016 DOI: 10.3389/fpubh.2021.731578] [Reference Citation Analysis]
5 Macaluso FS, Liguori G, Galli M. Vaccinations in patients with inflammatory bowel disease. Dig Liver Dis 2021:S1590-8658(21)00267-X. [PMID: 34116972 DOI: 10.1016/j.dld.2021.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schell TL, Richard LJ, Tippins K, Russ RK, Hayney MS, Caldera F. High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01308-2. [PMID: 34896281 DOI: 10.1016/j.cgh.2021.12.013] [Reference Citation Analysis]
7 Wellens J, Colombel JF, Satsangi JJ, Wong SY. SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges. J Crohns Colitis 2021;15:1376-86. [PMID: 33721882 DOI: 10.1093/ecco-jcc/jjab046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Quera R, Simian D, Núñez P, Flores L. Immunization in patients with inflammatory bowel disease: Still far from standards. Dig Liver Dis 2021;53:1519-20. [PMID: 34148863 DOI: 10.1016/j.dld.2021.05.030] [Reference Citation Analysis]
9 Chiarella-Redfern H, Lee S, Jubran B, Sharifi N, Panaccione R, Constantinescu C, Benchimol EI, Seow CH. Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants. Inflamm Bowel Dis 2021:izab033. [PMID: 33609034 DOI: 10.1093/ibd/izab033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]